Mobia Medical, Inc MOBI
—
9.06
0.25
2.84%
as of 25 Sep
- Market cap
- $293.3M
- P/E
- 0.0×
Follow MOBI
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+2 more TTM periods Free account |
— | — | — | 0.00% | |
| — | — | 0.00% | (61.37%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (1,242.56%) | |
Return on Tangible Assets |
— | 0.00% | 0.00% | (33.34%) | |
Average Days of Receivables |
— | 0.00 | 0.00 | 54.53 | |
Free Cash Flow per Share |
0.00 | 0.00 | (92.03) | (4.82) | |
Free Cash Flow |
— | (91.16) | (84.57) | (92.04) | |
Capital Expenditures |
— | (0.43) | (0.43) | (1.95) | |
Piotroski F-Score |
— | — | — | 0.00 | |
| Other line items | |||||
Cash ROIC |
0.00% | (130.14%) | (72.70%) | (25.24%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
— | — | — | 0.00 | |
Inventory Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
— | 0.00 | 0.00 | 130.48 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 384.36 | |
Tax Rate |
— | — | — | 0.00 | |
Research and Development Expense of Revenue |
— | — | — | 17.78% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 211.53% | |
Share Based Compensation of Revenue |
— | — | — | 6.91% | |
Interest Coverage |
— | — | — | 0.00 | |
Operating CF/Net income |
— | 0.00 | 0.00 | 1.50 | |
Depreciation/Fixed assets |
— | 0.63 | 0.61 | 0.28 | |
Capex/Depreciation |
— | (1.02) | (0.95) | (3.42) | |
Revenue per Share |
0.00 | — | 0.00 | 1.99 | |
Operating CF per Share |
0.00 | 0.00 | (91.56) | (4.72) | |
Capex per Share |
0.00 | 0.00 | (0.47) | (0.10) | |
Capex to Sales |
— | 0.00 | 0.00 | 0.05 | |
Net Profit Margin |
— | — | — | (158.06%) |
Columns are period end dates